Profile

Brain-on-a-chip tech powers neuroscience research

MOSAIC scholar engineers biomimetic model to tackle glioblastoma
Marissa Locke Rottinghaus
Nov. 4, 2024

A tiny device that fits into the palm of your hand may hold the key to recreating one of the body’s most intricate systems: the brain and its vascular network.

portrait of Brian O'Grady
Brian O'Grady

Brian O’Grady, a postdoctoral fellow at Vanderbilt University and an American Society for Biochemistry and Molecular Biology Maximizing Opportunities for Scientific and Academic Independent Careers, or MOSAIC, scholar, has developed a method to isolate blood vessels from postmortem human brain tissue and cultivate them in a hydrogel that mimics the brain’s natural environment. He calls this system a brain-on-a-chip. It’s about the size of a house key.

While pursuing his master’s degree in biology, O’Grady found himself craving more hands-on, practical work. He loved getting his hands dirty and repairing things, like his perpetually broken prized possession: a 1971 Corvette. So, he built a career in materials science and biomedical engineering.

“I really wanted to engineer solutions or create engineering components to solve important biological questions," O’Grady said.

But, what to build? He set his sights on creating a model system to test drugs for brain cancers such as glioblastoma.

Because the human brain is so complex, “clinical trials often fail,” O’Grady said. “They have over a 95% failure rate. It's just incredibly bad, so we need better models."

Historically, artificially recreating the extracellular matrix of the brain has stumped scientists because it contains dozens of components including glycosaminoglycans, proteoglycans, tenascins, collagens and more.

O’Grady’s setup overcomes this challenge using an essential molecule, N-cadherin peptide. This peptide bolsters the extracellular matrix of the brain-on-a-chip system and promotes cell survival and maturation.

“We used the peptide to trick neural cells into thinking that they're surrounded by other neural cells,” O’Grady said. “Normally cells in the brain are really, really tight and touching each other, so there's sort of a handshake between the cells. So, we took the peptide and put it on the backbone of the hydrogel, and the neural cells think they’re surrounded by other neural cells despite being surrounded by hydrogel.”

O’Grady’s brain-on-a-chip offers an unprecedented way to simulate the human brain’s vascular structure that could revolutionize drug testing and disease research, paving the way for advances in neuroscience and biotechnology.

He said he hopes this model system will improve the success rates of clinical trials by enabling preclinical testing in an environment that better recapitulates the elusive properties of the blood–brain barrier.

"If we can create something outside of the human body in a chip, … we can test compounds with a humanized system and see if we can find something that works better to get through the blood–brain barrier to reach those tumor cells."
 

(Farah Aziz Annesha contributed to this article.)

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Marissa Locke Rottinghaus

Marissa Locke Rottinghaus is the Editorial Content Manager for ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

In memoriam: Walter A. Shaw
In Memoriam

In memoriam: Walter A. Shaw

March 9, 2026

He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.

Dorn named assistant professor
Member News

Dorn named assistant professor

March 9, 2026

She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Kiessling wins glycobiology award
Member News

Kiessling wins glycobiology award

March 2, 2026

She was honored by the Society for Glycobiology for her work on protein–glycan interactions.

2026 ASBMB election results
Announcement

2026 ASBMB election results

Feb. 27, 2026

Meet the new Council members and Nominating Committee member.